ATE486602T1 - Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose - Google Patents

Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose

Info

Publication number
ATE486602T1
ATE486602T1 AT08736082T AT08736082T ATE486602T1 AT E486602 T1 ATE486602 T1 AT E486602T1 AT 08736082 T AT08736082 T AT 08736082T AT 08736082 T AT08736082 T AT 08736082T AT E486602 T1 ATE486602 T1 AT E486602T1
Authority
AT
Austria
Prior art keywords
tuberculosis
treatment
derivatives
quinolin
pyrrolo
Prior art date
Application number
AT08736082T
Other languages
English (en)
Inventor
Lluis Ballell-Pages
David Barros-Aguirre
Julia Castro-Pichel
Modesto Jesus Remuinan-Blanco
Jose Maria Fiandor-Roman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE486602T1 publication Critical patent/ATE486602T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT08736082T 2007-04-13 2008-04-10 Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose ATE486602T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07381033A EP1980251A1 (de) 2007-04-13 2007-04-13 Pyrrolo[3,2,1-ij]quinolin-4-on Derivate zur Behandlung der Tuberkulose
PCT/EP2008/054363 WO2008125594A1 (en) 2007-04-13 2008-04-10 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis

Publications (1)

Publication Number Publication Date
ATE486602T1 true ATE486602T1 (de) 2010-11-15

Family

ID=38456499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08736082T ATE486602T1 (de) 2007-04-13 2008-04-10 Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose

Country Status (8)

Country Link
US (1) US20100048544A1 (de)
EP (2) EP1980251A1 (de)
JP (1) JP2010523622A (de)
CN (1) CN101678015A (de)
AT (1) ATE486602T1 (de)
DE (1) DE602008003322D1 (de)
ES (1) ES2353631T3 (de)
WO (1) WO2008125594A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2340531T3 (es) * 2005-10-21 2010-06-04 Glaxo Group Limited Compuestos triciclos peri-condensados utiles como agentes antibacterianos.
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
ES2411930T3 (es) 2008-02-20 2013-07-09 Actelion Pharmaceuticals Ltd. Compuestos antibióticos azatricíclicos
DK2344495T3 (en) 2008-10-07 2015-02-02 Actelion Pharmaceuticals Ltd TRICYCLIC OXAZOLIDINON ANTIBIOTIC COMPOUNDS
WO2010118078A1 (en) 2009-04-08 2010-10-14 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors
TW201117812A (en) 2009-08-05 2011-06-01 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
EP2496578A4 (de) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac Imidazo[1,2-a]pyridin-verbindungen, ihre synthese und verfahren zu ihrer verwendung
US9353100B2 (en) 2011-02-10 2016-05-31 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
AR087875A1 (es) 2011-09-16 2014-04-23 Actelion Pharmaceuticals Ltd Proceso para la elaboracion de derivados de piridazina como intermediarios de sintesis de antibioticos
TW201326180A (zh) 2011-11-30 2013-07-01 Actelion Pharmaceuticals Ltd ３，７－二取代八氫－２Ｈ－吡啶并［４，３－ｅ］［１，３］□嗪－２－酮抗生素
EP3101012A1 (de) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Neue gadoliniumchelat-verbindung zur verwendung in der magnetresonanzbildgebung
CN108348510B (zh) 2015-09-17 2022-01-04 圣母大学 针对分枝杆菌感染有用的含有苄胺的杂环化合物以及组合物
ES2814555T3 (es) 2016-11-28 2021-03-29 Bayer Pharma AG Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética
KR102934987B1 (ko) 2018-11-23 2026-03-09 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법

Also Published As

Publication number Publication date
US20100048544A1 (en) 2010-02-25
JP2010523622A (ja) 2010-07-15
EP2136807A1 (de) 2009-12-30
ES2353631T3 (es) 2011-03-03
WO2008125594A1 (en) 2008-10-23
EP2136807B1 (de) 2010-11-03
EP1980251A1 (de) 2008-10-15
CN101678015A (zh) 2010-03-24
DE602008003322D1 (de) 2010-12-16

Similar Documents

Publication Publication Date Title
ATE486602T1 (de) Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose
MX2012008049A (es) Compuestos heterociclicos triciclicos, composiciones y metodos de uso de los mismos,.
CL2011000729A1 (es) Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
EA201200951A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
MY145133A (en) Aryl-substituted polycyclic amines, process for their preparation and their use as medicaments
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
CL2007001554A1 (es) Compuestos derivados de pirido [3,2-e]pirazinas;inhibidoras de pde10;procedimiento de preparacion;composicion farmaceutica que comprende; kit farmaceutico; uso para preparar de un medicamento para tratar o prevenir trastornos asociados a la hiperactividad de pde10 y/o trastornos en los que inhibir la pde10 es de valor.
CA2603830A1 (en) PYRIDINE [2,3-B] PYRAZINONES
CL2008001345A1 (es) Compuestos derivados de imidazo[1,2-b]piridazinas, inhibidores de cinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; su proceso de preparacion; y su uso en enfermedades hiperproliferativas, inflamatorias, alergicas y obstructivas de las vias respiratorias, entre otras.
UA100400C2 (uk) Похідні спіроциклічних амідів
CL2008001122A1 (es) Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
CL2011000116A1 (es) Compuestos derivados de imidazo[1,2-a]piridina; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y uso en el tratamiento del cancer.
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
WO2007146124A3 (en) Deuterated tadalafil derivatives
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
MX2009002842A (es) Inhibidores heterociclicos de c-met y usos de los mismos.
IL190774A0 (en) Pharmaceutical compositions containing a jorumycin-renieramycin-or saframycin-related compounds for treating proliferative diseases
EA201071352A1 (ru) Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств
WO2006092599A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
ATE356131T1 (de) Tricyclische imidazopyridine
DE502006004182D1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2-aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln
WO2006087544A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2006087548A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties